Inhaled corticosteroids in childhood asthma

Santos, José Manuel Lopes dos

doi:10.1002/ppul.1950230856

Cited by 3 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This fact is not associated with the disease severity or treatment. 1,[7][8][9][10][11][12][13][14][15][16][17][18][19] Growth delay in asthmatic children is associated with delayed bone maturation, and height-forage remains compatible with skeletal age. 7,17,20 Therefore, growth can "catch up", and normal or expected final adult height can be attained.…”

Section: Factors That Influence Normal Growthmentioning

confidence: 99%

Inhaled corticosteroids and growth - a review

Fortk¹,

Brown²

2000

J Pediatr (Rio J)

View full text Add to dashboard Cite

Objective: the aim of this review was to evaluate the medical literature in the last 10 years regarding the impact of the use of inhaled corticosteroids in children's and adolescents' growth. Methods: literature review. Results: the use of inhaled corticosteroids in childhood asthma in dosages appropriate to its severity does not seem to impair adult height. Conclusions: the use of inhaled corticosteroids in childhood asthma does not seem to impair growth. However, it is prudent to use the lowest possible dose necessary to achieve a good clinical control of asthma, as well as to monitor the growth of any child/adolescent receiving inhaled corticosteroids.

show abstract

Section: Factors That Influence Normal Growthmentioning

confidence: 99%

Inhaled corticosteroids and growth - a review

Fortk¹,

Brown²

2000

J Pediatr (Rio J)

View full text Add to dashboard Cite

show abstract

“…Bronchial asthma is a chronic disease characterized by bronchial hypersensitivity, increased responsiveness of the airway and variable airway obstruction as a result of chronic airway inflammation [1][2][3]. Paroxysmal coughing, dyspnea, wheezing and chest tightness occur as a result of this inflammation in the airways of sensitive people.…”

Section: Introductionmentioning

confidence: 99%

Seropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children

Tutanç¹,

Gürkan²,

Yel³

et al. 2015

Ann Clin Anal Med

View full text Add to dashboard Cite

Anahtar KelimelerBronşiyal Astım; Chlamydia Pneumoniae; Mycoplasma Pneumoniae; Çocuk Abstract Acute respiratory tract infections may trigger acute asthma attacks and may be held responsible for etiopathogenesis in children with asthma. Although bacterial infections attract a limited amount of attention, recently Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP), in particular, are reported to be the possible factors. IgM and IgG seroprevalence was investigated in 66 children patients with bronchial asthma (between the ages of 3 and 14) for CP and Mycoplasma pneumoniae. In a total of 66 cases, 18 (27.2%) patients were detected with IgG positivity for CP whereas 27 of them (40.9%) were detected with IgG positivity for MP. IgG positivity was determined in 6 patients (13.0%) in the control group for CP, and in 6 patients (10.8%) in the control group for MP. The rate of the asthma patients with IgG seropositivity for MP was 4 times higher than that of the control group. It was seen that IgG antibody seropositivity for CP was higher in those with more frequent attacks. No such difference was observed in terms of IgG antibody seropositivity for M. pneumoniae. There are many studies indicating that CP and MP infections take an importance place in the etiology of bronchial asthma and asthma attacks in children. The results obtained reveal the effect of both microorganisms on the etiopathogenesis of the bronchial asthma and the increased number of asthma attacks.

show abstract

“…Astım çocukluk çağında dünyada en sık görülen kronik hastalıklardan biridir. Bronşial astım kronik hava yolu inflamasyonu sonucu gelişen bronşial aşırı duyarlılık, hava yolu cevaplılığındaki artış, değişken hava yolu obstrüksiyonu ile karakterize klinik bir sendrom ve kronik bir çocukluk çağı hastalığı olarak tanımlanmaktadır [1]. Astım sonuçları ile bireyi, aileyi ve toplumu ciddi biçimde etkiler.…”

Section: Introductionunclassified

Assesment of Quality of Life in Children with Asthma

Gümüş¹

2012

Ann Clin Anal Med

View full text Add to dashboard Cite

Bronşiyal astım, fiziksel, duygusal ve sosyal yönlerden hastanın yaşamında değişik oranlarda kısıtlamalara yol açabilen, en yaygın kronik çocukluk hastalıkları arasındadır. Bu çalışmanın amacı astmatik çocuklarda yaşam kalitesindeki bozulmayı değerlendirmektir. Gereç ve Yöntem: Dicle Üniversitesi Çocuk Göğüs Hastalıkları Bölümünde Ekim 2009-Ocak 2010 tarihleri arasında izlenen 7-15 yaş arası 97 hasta çalışmaya alındı. Yaşam kalitesini değerlendirmek için Çocuk Yaşam Kalitesi Anketi'nin (PAQLQ) Türkçe versiyonu kullanıldı. İlaveten Çocukluk Çağı Astma Kontrol Testi kullanılarak astım şiddeti ölçüldü. Bulgular: Astmatik çocukların erkek/kız oranı 2/1 ve yaş ortalaması 10.0 ± 2.5 yıl idi. Astma şiddeti, steroid kullanım anamnezi ve düşük aile gelir düzeyi PAQLQ skoru üzerinde olumsuz etkili bulundu (p<0.001). Babanın eğitim düzeyi, hastanın yaşı, cinsiyeti, pasif sigara maruziyeti, ailede astma veya egzema varlığı öyküsü ve hastalık süresinin PAQLQ skoru üzerinde istatistiksel olarak anlamlı bir etkiye sahip değildi (p>0.05). Astma Kontrol Test skoru, PAQLQ skoru ile anlamlı korelasyon gösterdi (p<0.001). Sonuç: Steroid kullanımı, astma şiddeti ve ailenin düşük sosyo-ekonomik durumu astımlı çocukların yaşam kalitesi üzerinde olumsuz etkiye sahiptir.

show abstract

Inhaled corticosteroids in childhood asthma

Cited by 3 publications

References 10 publications

Inhaled corticosteroids and growth - a review

Inhaled corticosteroids and growth - a review

Seropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children

Assesment of Quality of Life in Children with Asthma

Contact Info

Product

Resources

About